Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Neoadjuvant Doxorubicin and Cyclophosphamide Followed by Docetaxel and S-1 in Breast Cancer

NCT00994968 is registered in ClinicalTrials.gov with Yonsei University as lead sponsor.

NCT NCT00994968
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00994968 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Neoadjuvant Doxorubicin and Cyclophosphamide Followed by Docetaxel and S-1 in Breast Cancer
Lead sponsor
Yonsei University
Phase
Phase 2
Overall status
Unknown status
Start date
July 31, 2009
Completion date
Not reported
Enrollment
49 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

breast cancer